Videos

Selected Videos:

• SNMMIChannel – Best Article of the Month (Feb. 2018)
  PSMA PET/CT Visualizes Prostate Cancer Recurrence Early, Impacts Radiation Therapy(Link is external) (Link opens in new window)
• SNMMIChannel – Best Clinical Investigation of the Month (Nov. 2018)
  Prostate Cancer Radiotherapy More Precisely Targeted with Nuclear Medicine Imaging(Link is external) (Link opens in new window)
• Urotoday - PCF Carlsbad 2018
  Effectiveness and Resistance to PSMA Targeted RadioLigand Therapy using 177 Lu-PSMA-617(Link is external) (Link opens in new window) 
• VJOncology – ASCO GU San Francisco 2019
  Gallium-labelled PSMA-11 PET/CT and it’s benefits(Link is external) (Link opens in new window)
  Fluorine-18 FACBC vs. Gallium-labelled PSMA-11 PET/CT for prostate cancer screening(Link is external) (Link opens in new window)
  Prostate cancer radiotherapy planning with Gallium-labelled PSMA-11 PET/CT imaging(Link is external) (Link opens in new window)
• Targeted Oncology – AUA Chicago 2019
  Analyzing Responses to 177LuPSMA-617 in Patients With Metastatic CRPC(Link is external) (Link opens in new window)
• VJOncology – ASCO Chicago 2019
  PSMA vs AXUMIN PET/CT in prostate cancer(Link is external) (Link opens in new window)
  Molecular imaging for prostate cancer salvage radiotherapy planning(Link is external) (Link opens in new window)
  Challenges with novel molecular imaging techniques for prostate cancer(Link is external) (Link opens in new window)
• SAR -  Prostate Disease Focused Panel Podcast 
  Hot of the Press: PSMA vs Fluciclovine PET/CT for Detection of Prostate Cancer Recurrence(Link is external) (Link opens in new window)
• SNMMIChannel – Best Clinical Investigation of the Month (Sep. 2019)
  PET Offers More Precise Screening Method to Select Candidates for Neuroendocrine Tumor Therapy(Link is external) (Link opens in new window)
• VJOncology – ASCO GU San Francisco 2020
  The significant impact of PSMA-PET on prostate cancer staging and management(Link is external) (Link opens in new window)
• eCancer – ASCO GU San Francisco 2020
  Prostate-specific membrane antigen PET: Who should undergo advanced imaging?(Link is external) (Link opens in new window)
• Urotoday – ASCO GU San Francisco 2020
  PSMA PET Diagnostic Imaging in the Current Era(Link is external) (Link opens in new window)

• VuMedi – ASCO 2020
  2020 ASCO Update on mCRPC: What Is the OS After 177Lu-PSMA-617 Molecular Radiotherapy?(Link is external) (Link opens in new window)

• VuMedi – UCLA Health
  Prostate Cancer PET Imaging Biological Target: FACBC vs PSMA PET/CT - Which Option Should Be the Imaging Modality of Choice in Patients With post-RP early BCR? What Is the Best PET Target for Early Biochemical Recurrence of Prostate Cancer?(Link is external) (Link opens in new window)

• VuMedi – UCLA Health 
  PSMA PET/CT Imaging in Prostate Cancer: GALLIUM-68 vs FLUOR-18 PSMA-PET - Which Option Matters for Detection/Localization of Disease? What Is the Impact on Drug Indication?(Link is external) (Link opens in new window)

• VuMedi – UCLA Health 
  PSMA PET Imaging for Primary Staging: Efficacy Analysis of Methods for Ruling-out N1 and M1b Disease?(Link is external) (Link opens in new window)